An unusual ryanodine receptor 1 (RYR1) phenotype
Manu Jokela(Tampere University), Bjarne Udd(Folkhälsans Forskningscentrum), Sanna Huovinen(Vaasa Central Hospital), Pirjo Isohanni(University of Helsinki), Päivi Hartikainen(Turku University Hospital), Maria Alice Donati(University of Florence), Eugenio Mercuri(Università Cattolica del Sacro Cuore), Marika Pane(Università Cattolica del Sacro Cuore), Johanna Palmio, Giorgio Tasca(Agostino Gemelli University Polyclinic), Per Harald Jonson(VTT Technical Research Centre of Finland), Marco Savarese(Folkhälsans Forskningscentrum), Anna Vihola(University of Helsinki), Mridul Johari(University of Helsinki), Salla Välipakka(Turku University Hospital), Sara Lehtinen(Fimlab (Finland))
Cited by 21
Related Papers
MELAS: Clinical features, biochemistry, and molecular genetics
|Annals of Neurology|1992|508
Longitudinal effect of eteplirsen versus historical control on ambulation in <scp>D</scp> uchenne muscular dystrophy
|Annals of Neurology|2015|502
The myotonic dystrophies: molecular, clinical, and therapeutic challenges
|The Lancet Neurology|2012|487
Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein Titin
|The American Journal of Human Genetics|2002|484
FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study
|The Lancet Neurology|2011|420